Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2022;33(2):247-51
Article Links
Intestinal Peripheral T-Cell Lymphoma in a Patient with Ankylosing Spondylitis Under Treatment with Infliximab: A Case Report and Review of the Literature
Firdevs Ulutaş1, Cansu Korkmaz2, Halil Yılmaz3, Duygu Akça4, Erdem Çomut4, Mustafa Çelık3, Veli Çobankara1
Authors Information

1Division of Rheumatology, Department of Internal Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey

2Department of Internal Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey

3Division of Gastroenterology, Department of Internal Medicine, Pamukkale University Faculty of Medicine, Denizli, Turkey

4Department of Pathology, Pamukkale University Faculty of Medicine, Denizli, Turkey

F Ulutaş, C Korkmaz, H Yılmaz, D Akça, E Çomut, M Çelık, V Çobankara

Keywords: ankylosing spondylitis, Crohn's disease, lymphoma, inflammation
References
  1. Carbone A, Tripodo C, Carlo-Stella C, Santoro A, Gloghini A. The role of inflammation in lymphoma. Adv Exp Med Biol 2014;816:315-33.
  2. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity.  Curr Opin Rheumatol 2006;8:129-34. 
  3. Smedby KE, Backlund E, Askling J. Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 2006;15(11):2069-77.
  4. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104(4):487-501.
  5. Goujon C, Bachelet H. Infliximab. Ann Dermatol Venereol 2019;146(6-7):483-6.
  6. Mariette X, Tubach F, Bagheri H, Bardet M, Berthelot JM, Gaudin P, et al. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis 2010;69(2):400-8.
  7. Deng C, Li W, Fei Y, Li Y, Zhang F. Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis. Sci Rep 2016(18);6:32063.
  8. Askling J, Klareskog L, Blomqvist P, Ford M, Feltelius N. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis 2006;65(9):1184-7.
  9. Hellgren K, Smedby KE, Backlin C, Sundstrom C, Feltelius N, Eriksson JK, et al. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Arthritis Rheumatol 2014;66(5):1282-90.
  10. Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, et al. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers. Ann Rheum Dis 2017;76(1):105-11.
  11. Aksu K, Cagirgan S, Ozsan N, Keser G, Sahin F. Non-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis. Rheumatol Int 2011 Dec;31(12):1645-7.
  12. Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Practice Res Clin Rheumatol 2006(1);20(3): 451-71.
  13. Jantunen E, Myllykangas-Luosujarvi R, Kaipiainen-Seppanen O, Nousiainen T. Autologous stem cell transplantation in a lymphoma patient with a long history of ankylosing spondylitis. Rheumatology (Oxford) 2000;39(5):563-4.
  14. Gau JP, Chiu CF, Liu SM, Hsu HC, Ho CH, Chau WK. Angiotropic lymphoma manifesting as a solitary adrenal tumor in a case of ankylosing spondylitis. Zhonghua Yi Xue Za Zhi (Taipei) 2000 Jan;63(1):62-5.
  15. Pavithran K, Raji NL, Thomas M. Ankylosing spondylitis associated with non-Hodgkin's lymphoma. J Assoc Physicians India 2002;50:836-7.
  16. Khan SY, Hutchinson DG. Primary synovial non-Hodgkin's lymphoma in association with ankylosing spondylitis. Rheumatology (Oxford) 2004;43(3):391.
  17. Dauendorffer JN, Rivet J, Allard A, Bachelez H. Sezary syndrome in a patient receiving infliximab for ankylosing spondylitis. Br J Dermatol 2007;156(4):742-3.
  18. Aksu K, Donmez A, Ertan Y, Keser G, Inal V, Oder G, et al. Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis. Rheumatol Int 2007;28(2):185-7.
  19. Sanli H, Ataman S, Akay BN, Yilmaz A, Yildizlar D, Gürgey E. Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy. J Drugs Dermatol 2007;6(8):834-6.
  20. Xu L. Ankylosing spondylitis combined with angioimmunoblastic T cell lymphoma. BMJ Case Rep 2011(5);2011:bcr0520114245.
  21. Kim YS, Kim HS. Ankylosing spondylitis accompanying Hodgkin's lymphoma. Int J Rheum Dis 2012;15(4):e68-70.
  22. Jung KH, Lim MJ, Kwon SR, Joo KW, Yi HG, Choi SJ, et al. Angioimmunoblastic T cell lymphoma in an ankylosing spondylitis patient treated with etanercept. Mod Rheumatol 2013;23(4):817-22.
  23. Monti S, Boffin N, Lucioni M, Paulli M, Montecucco C, Caporali R. Spinal non-Hodgkin's lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents: case report and review of the literature. Clin Rheumatol 2016;35(1):275-80.
  24. Stoicanescu LD, Cevei ML, Sirbu EM, Zdrinca MM, Muţiu G. Unusual occurrence of avascular necrosis with bilateral involvement and ankylosing spondylitis, meningioma, and Hodgkin lymphoma. Rom J Morphol Embryol 2019;60(3):1003-7.
  25. Toussirot E, Houvenagel E, Goeb V, Fouache D, Martin A, Le Dantec P, et al. Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide series. Joint Bone Spine 2012 Oct;79(5):457-63.
  26. Kolarz B, Targońska-Stepniak B, Darmochwał-Kolarz D, Majdan M. Autoimmune aspects of treatment with TNF-alpha inhibitors. Postepy Hig Med Dosw (Online) 2007(28);61:478-84.
  27. Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, et al. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease. Gastroenterology 2020;158(1):189-199.
  28. Murdaca G, Spano F, Contatore M, Guastalla A, Penza E, Magnani O, Puppo F. Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety? Expert Opin Drug Saf 2016;15(1):43-52.
  29. Hyams JS, Goldman H, Katz AJ. Differentiating small bowel Crohn's disease from lymphoma. Role of rectal biopsy. Gastroenterology 1980;79(2):340-3.
  30. Sachar DB. Small Bowel Lesions Mimicking Crohn's Disease. Curr Gastroenterol Rep 2018(6);20(9):43. 
  31. Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001;33(4):267-82.
  32. Rubesin SE, Gilchrist AM, Bronner M, Saul SH, Herlinger H, Grumbach K, Levine MS, Laufer I. Non-Hodgkin lymphoma of the small intestine. Radiographics 1990;10(6):985-98.
  33. Nakamura S, Matsumoto T, Takeshita M, Kurahara K, Yao T, Tsuneyoshi M, et al. A clinicopathologic study of primary small intestine lymphoma: prognostic significance of mucosa-associated lymphoid tissue-derived lymphoma. Cancer 2000(15);88(2):286-94.
  34. Lu XH, Yu YJ, Tan SY, Ding YJ. Primary Small Intestinal Diffuse Large B-cell Lymphoma Masquerading as Crohn's Disease: A Case Report. Chin Med J (Engl) 2017(5);130(17):2138-9.